These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 26728342

  • 1. Potency of umbilical cord blood- and Wharton's jelly-derived mesenchymal stem cells for scarless wound healing.
    Doi H, Kitajima Y, Luo L, Yan C, Tateishi S, Ono Y, Urata Y, Goto S, Mori R, Masuzaki H, Shimokawa I, Hirano A, Li TS.
    Sci Rep; 2016 Jan 05; 6():18844. PubMed ID: 26728342
    [Abstract] [Full Text] [Related]

  • 2. Impact of Cryopreservation on Caprine Fetal Adnexa Derived Stem Cells and Its Evaluation for Growth Kinetics, Phenotypic Characterization, and Wound Healing Potential in Xenogenic Rat Model.
    Somal A, Bhat IA, B I, Singh AP, Panda BSK, Desingu PA, Pandey S, Bharti MK, Pal A, Saikumar G, Chandra V, Sharma GT.
    J Cell Physiol; 2017 Aug 05; 232(8):2186-2200. PubMed ID: 27966782
    [Abstract] [Full Text] [Related]

  • 3. A comparison of Wharton's jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy.
    El-Demerdash RF, Hammad LN, Kamal MM, El Mesallamy HO.
    Regen Med; 2015 Aug 05; 10(7):841-55. PubMed ID: 26541176
    [Abstract] [Full Text] [Related]

  • 4. The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.
    Lee S, Park BJ, Kim JY, Jekarl D, Choi HY, Lee SY, Kim M, Kim Y, Park MS.
    Cytotherapy; 2015 Dec 05; 17(12):1723-31. PubMed ID: 26589753
    [Abstract] [Full Text] [Related]

  • 5. Repair and regeneration of skin injury by transplanting microparticles mixed with Wharton's jelly and MSCs from the human umbilical cord.
    Zhang Y, Hao H, Liu J, Fu X, Han W.
    Int J Low Extrem Wounds; 2012 Dec 05; 11(4):264-70. PubMed ID: 23089966
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic Application of Human Wharton Jelly Mesenchymal Stem Cells in Skin Injury of SCID.
    Sabapathy V, Sundaram B, Kumar S.
    Methods Mol Biol; 2017 Dec 05; 1553():115-132. PubMed ID: 28229411
    [Abstract] [Full Text] [Related]

  • 7. Mesenchymal stromal cells of human umbilical cord Wharton's jelly accelerate wound healing by paracrine mechanisms.
    Shohara R, Yamamoto A, Takikawa S, Iwase A, Hibi H, Kikkawa F, Ueda M.
    Cytotherapy; 2012 Nov 05; 14(10):1171-81. PubMed ID: 22900957
    [Abstract] [Full Text] [Related]

  • 8. Cycloxygenase-2 inhibition potentiates trans-differentiation of Wharton's jelly-mesenchymal stromal cells into endothelial cells: Transplantation enhances neovascularization-mediated wound repair.
    Kaushik K, Das A.
    Cytotherapy; 2019 Feb 05; 21(2):260-273. PubMed ID: 30738643
    [Abstract] [Full Text] [Related]

  • 9. Human Wharton's Jelly Mesenchymal Stem Cells plasticity augments scar-free skin wound healing with hair growth.
    Sabapathy V, Sundaram B, V M S, Mankuzhy P, Kumar S.
    PLoS One; 2014 Feb 05; 9(4):e93726. PubMed ID: 24736473
    [Abstract] [Full Text] [Related]

  • 10. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.
    Li Q, Zhao D, Chen Q, Luo M, Huang J, Yang C, Wang F, Li W, Liu T.
    Stem Cell Res Ther; 2019 Dec 05; 10(1):376. PubMed ID: 31806004
    [Abstract] [Full Text] [Related]

  • 11. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
    Donders R, Vanheusden M, Bogie JF, Ravanidis S, Thewissen K, Stinissen P, Gyselaers W, Hendriks JJ, Hellings N.
    Cell Transplant; 2015 Dec 05; 24(10):2077-98. PubMed ID: 25310756
    [Abstract] [Full Text] [Related]

  • 12. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.
    Kim MJ, Shin KS, Jeon JH, Lee DR, Shim SH, Kim JK, Cha DH, Yoon TK, Kim GJ.
    Cell Tissue Res; 2011 Oct 05; 346(1):53-64. PubMed ID: 21987220
    [Abstract] [Full Text] [Related]

  • 13. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L, Badraiq H, Galleu A, Taheem DK, Codognotto S, Siow R, Khalaf Y, Briley A, Shennan A, Poston L, McGrath J, Gentleman E, Dazzi F, Ilic D.
    Regen Med; 2014 Oct 05; 9(6):723-32. PubMed ID: 25431909
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
    Ranjbaran H, Abediankenari S, Mohammadi M, Jafari N, Khalilian A, Rahmani Z, Momeninezhad Amiri M, Ebrahimi P.
    Acta Med Iran; 2018 Jan 05; 56(1):28-33. PubMed ID: 29436792
    [Abstract] [Full Text] [Related]

  • 16. Circular RNAs are abundantly expressed and upregulated during repair of the damaged endometrium by Wharton's jelly-derived mesenchymal stem cells.
    Sun B, Shi L, Shi Q, Jiang Y, Su Z, Yang X, Zhang Y.
    Stem Cell Res Ther; 2018 Nov 15; 9(1):314. PubMed ID: 30442201
    [Abstract] [Full Text] [Related]

  • 17. Wharton's Jelly Mesenchymal Stromal Cells Support the Expansion of Cord Blood-derived CD34+ Cells Mimicking a Hematopoietic Niche in a Direct Cell-cell Contact Culture System.
    Lo Iacono M, Russo E, Anzalone R, Baiamonte E, Alberti G, Gerbino A, Maggio A, La Rocca G, Acuto S.
    Cell Transplant; 2018 Jan 15; 27(1):117-129. PubMed ID: 29562783
    [Abstract] [Full Text] [Related]

  • 18. Role of Nonmuscle Myosin II in Migration of Wharton's Jelly-Derived Mesenchymal Stem Cells.
    Arora S, Saha S, Roy S, Das M, Jana SS, Ta M.
    Stem Cells Dev; 2015 Sep 01; 24(17):2065-77. PubMed ID: 25923805
    [Abstract] [Full Text] [Related]

  • 19. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction.
    Zhang J, Chen GH, Wang YW, Zhao J, Duan HF, Liao LM, Zhang XZ, Chen YD, Chen H.
    Chin Med J (Engl); 2012 Oct 01; 125(19):3472-8. PubMed ID: 23044308
    [Abstract] [Full Text] [Related]

  • 20. Silk fibroin scaffolds seeded with Wharton's jelly mesenchymal stem cells enhance re-epithelialization and reduce formation of scar tissue after cutaneous wound healing.
    Millán-Rivero JE, Martínez CM, Romecín PA, Aznar-Cervantes SD, Carpes-Ruiz M, Cenis JL, Moraleda JM, Atucha NM, García-Bernal D.
    Stem Cell Res Ther; 2019 Apr 27; 10(1):126. PubMed ID: 31029166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.